Gamma-vitamin E study

Completed

• Conditions: Risk factors for heart disease in type 2 diabetics; Metabolic and Endocrine - Diabetes; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12605000093684
• Lead Sponsor: niversity of Western Australia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Type 2 diabetes.

Exclusion Criteria

Type 1 diabetes, insulin use, pure vitamin E/tocopherol supplements, NSAIDs, smoking, recent CVD event, renal impairment, BMI>35, high alcohol intake.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Inflammation[At baseline and following the 6 week intervention];Oxidative stress (including neutrophil function)[At baseline and following the 6 week intervention];Cellular enrichment[At baseline and following the 6 week intervention]

Secondary Outcome Measures

Name	Time	Method
Blood pressure[At baseline and following 6 week intervention.];Vascular function[At baseline and following 6 week intervention.]